Average Co-Inventor Count = 3.75
ph-index = 15
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Alkermes Pharma Ireland Limited (16 from 160 patents)
2. Alkermes Controlled Therapeutics, Inc. II (13 from 36 patents)
3. Alkermes, Inc. (10 from 75 patents)
4. Amylin Pharmaceuticals, Inc. (3 from 164 patents)
5. Alkermes Controlled Therapeutics, Inc. (1 from 46 patents)
6. Alkernnes Pharma Ireland Limited (1 from 1 patent)
7. Alkermas Controlled Therapeutics Inc. II (1 from 1 patent)
8. Morales Wilfredo Jr. (0 patent)
42 patents:
1. 11883394 - Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
2. 10973816 - Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
3. 10478434 - Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
4. 10328070 - Polymorphic forms of naltrexone
5. 10166228 - Polymorphic forms of naltrexone
6. 10064859 - Crystallization process of aripiprazole derivatives in extended release formulations for treatment of schizophrenia
7. 9980958 - Polymorphic forms of naltrexone
8. 9827240 - Polymorphic forms of naltrexone
9. 9556189 - Polymorphic forms of naltrexone
10. 9365580 - Polymorphic forms of naltrexone
11. 9238076 - Polymer-based sustained release device
12. 9221830 - Polymorphic forms of naltrexone
13. 8975272 - Polymorphic forms of naltrexone
14. 8877252 - Polymer-based sustained release device
15. 8735420 - Polymorphic forms of naltrexone